Stock listing
Frankfurt:UR8 UroGen Pharma Ltd. Aktie
German listing (Frankfurt) of UroGen Pharma Ltd. · home listing NASDAQ:URGN
Follow UroGen Pharma Ltd. into a list and get an email when it puts out news.
Share price · FWB:UR8
€29.45 EUR -1.05 (-3.4%)
Close on Oct 30, 2026
- Day range
- €29.45 – €29.45 EUROct 30, 2026
- Market cap
- €1.44B EURAt the close on Oct 30, 2026 · price × 48.88M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:URGN · Home | $32.72 USD | -0.76 (-2.3%) | 1,166,116 | $33.14 | $33.65 | $32.39 | $33.48 | Close on Oct 30, 2026 |
| LSE:0XOD | $33.90 USD | -1.05 (-3.0%) | 231 | $34.20 | $34.50 | $33.50 | $34.95 | Close on Oct 27, 2026 |
| Frankfurt:UR8 | €29.45 EUR | -1.05 (-3.4%) | — | €29.45 | €29.45 | €29.45 | €30.50 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:UR8
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer
Latest earnings call · Aug 5, 2026
Urogen Pharma (NASDAQ:URGN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 30 slides
Calls
Upcoming
Urogen Pharma (NASDAQ:URGN) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 10:00 AM ET
Register
Replays
Urogen Pharma (NASDAQ:URGN) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 10:00 AM ET
Watch TranscriptUrogen Pharma (NASDAQ:URGN) Q1 2026 Earnings Call
Wed, May 06, 2026 · 10:00 AM ET
Watch TranscriptUrogen Pharma (NASDAQ:URGN) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 10:00 AM ET
Watch Transcript
Latest news
Financings
Strategic investment of equity securities
Aug 20, 2026
Announced: up to US$7M
Buyers: UroGen Pharma Ltd. (up to $7 million in the equity securities of IntraGel)
Use of proceeds: Phase 2 clinical development of TumoCure for advanced head and neck cancer
Decks
Investor Presentation (August 2026)
Investor deck · 30 slides · August 2026
Investor Presentation (January 2025)
Investor deck · 44 slides · Jan 14, 2025
Technical Presentation (June 2024)
Technical · 57 slides · Jun 13, 2024
Investor Presentation (March 2024)
Investor deck · 56 slides · Mar 4, 2024
UroGen Pharma Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 31 in the last 12 months · 202 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Aug 5, 2026
- Decks
- 10 decks · latest August 2026
Where UroGen Pharma Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:URGN · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2DTCV | LS Exchange | Germany | EUR |
| gettex:UR8 | gettex | Germany | EUR |
| Lang & Schwarz:A2DTCV | Lang & Schwarz | Germany | EUR |
| LSE:0XOD | LSE | United Kingdom | USD |
| BOATS:URGN | BOATS | United States | USD |
| Frankfurt:UR8 · This page | Frankfurt | Germany | EUR |
| Dusseldorf:UR8 | Dusseldorf | Germany | EUR |
| Munich:UR8 | Munich | Germany | EUR |
| Stuttgart:UR8 | Stuttgart | Germany | EUR |
| Tradegate:UR8 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about UroGen Pharma Ltd.